Weekly Market Roundup

  • RenovoRx Hits 52-Week High as Revenue and Trial News Align

    RenovoRx Hits 52-Week High as Revenue and Trial News Align

    RenovoRx spent August checking boxes most microcap biotechs take years to check. A pivotal trial finished enrolling. Quarterly revenue kept climbing. A Nasdaq compliance problem got resolved. By month’s end, the stock was sitting at a 52-week high. RenovoRx Hits 52-Week High as Revenue Growth and Trial Enrollment Both Deliver RenovoRx (Nasdaq: RNXT) shares rose…

    read more

  • Gold Miners Post Their Best Month Ever. Juggernaut Exploration Confirms a 600-Meter Gold Zone. Bitcoin Clears $80,000.

    Gold Miners Post Their Best Month Ever. Juggernaut Exploration Confirms a 600-Meter Gold Zone. Bitcoin Clears $80,000.

    Gold miners just had their best month on record, gaining more than chip stocks managed even at their hottest. A driller in British Columbia’s Golden Triangle confirmed a new mineralized zone extends 600 meters along strike and 580 meters deep, with assays still to come. Bitcoin cleared $80,000 for the first time in three months,…

    read more

  • Pirate Gold, Churchill Resources, Copper Giant Report Fresh Assays

    Pirate Gold, Churchill Resources, Copper Giant Report Fresh Assays

    Newfoundland has quietly turned into one of the busier corners of Canadian exploration this year, and this week two companies were drilling barely a province apart from each other, one chasing gold, the other chasing a polymetallic vein swarm nobody had mapped a year ago. A third story landed much further south, where a single…

    read more

  • Future FinTech Group Executes Third Reverse Split Since January as Hedgeye Launches Hedged Bitcoin ETF

    Future FinTech Group Executes Third Reverse Split Since January as Hedgeye Launches Hedged Bitcoin ETF

    A Nasdaq-listed fintech company just did something it’s now done three times since January: shrink its own share count to stay above the exchange’s minimum bid price. Bitcoin sits nearly 40% below its October high. A new ETF just launched specifically to help investors stomach swings that size without giving up all the upside. Future…

    read more

  • Eric Sprott Lifts MAX Power Mining Stake to 24.35%

    Eric Sprott Lifts MAX Power Mining Stake to 24.35%

    Billionaire investor Eric Sprott just wrote a $6 million check to increase his stake in a natural hydrogen explorer, days after shareholders voted almost unanimously to clear the way. A Quebec graphite developer signed a new partnership aimed at cutting the cost of turning its ore into finished battery material. Eric Sprott Lifts MAX Power…

    read more

  • Gorilla Technology Revenue Surge, BeWhere Record Profit

    Gorilla Technology Revenue Surge, BeWhere Record Profit

    Gorilla Technology just reported the kind of revenue growth most companies only dream about, and the stock dropped anyway. A much smaller asset-tracking company reported the opposite problem: revenue that actually fell, alongside its most profitable quarter on record. Both companies spent the same week proving that a single headline number rarely tells the whole…

    read more

  • Capricor Gains 11% as FDA Pushes Deramiocel Decision to Nov

    Capricor Gains 11% as FDA Pushes Deramiocel Decision to Nov

    A three-month delay is not usually something a stock rallies on. Capricor Therapeutics gained 11% anyway. The company’s Duchenne muscular dystrophy therapy just got a longer FDA review instead of a decision, and investors treated the extra scrutiny as a sign the door stayed open rather than a rejection in slow motion. Capricor Gains 11%…

    read more

  • Goliath, Selkirk Copper, Westhaven Gold Report Fresh Assays

    Goliath, Selkirk Copper, Westhaven Gold Report Fresh Assays

    Visible gold to the naked eye is rare enough in a drill core that companies usually lead with it. This week one company had it running through more than 35 metres of continuous mineralization, not a single flash in an otherwise ordinary hole. Two copper-and-gold projects further north and further west had their own strong…

    read more

  • A Rare Earth Rally, an MS Drug Trial Clearance, and Bitcoin Above $77,000

    A Rare Earth Rally, an MS Drug Trial Clearance, and Bitcoin Above $77,000

    The market took two weeks to notice a rare earth resource update, then made up for lost time all at once. A multiple sclerosis drug cleared the FDA for human trials after spending the spring on clinical hold. Bitcoin climbed above $77,000 and pulled a handful of large, US-listed crypto names along with it, though…

    read more

  • AmeriTrust Financial Technologies Expands Into Texas as SEC Proposes First-Ever Crypto Asset Offering Rules

    AmeriTrust Financial Technologies Expands Into Texas as SEC Proposes First-Ever Crypto Asset Offering Rules

    A Toronto-based auto-lease fintech company just picked up two new licenses in one of the largest car markets in the country. The same week, the SEC proposed the first regulatory framework written specifically for crypto asset offerings in the agency’s history. One company expanding into Texas. One regulator finally writing down rules an entire industry…

    read more